Previous close | 0.0110 |
Open | 0.0110 |
Bid | 0.0100 x 250000 |
Ask | 0.0110 x 1097400 |
Day's range | 0.0110 - 0.0110 |
52-week range | 0.0080 - 0.0275 |
Volume | |
Avg. volume | 0 |
Market cap | 1.933M |
Beta (5Y monthly) | 1.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0900 |
Earnings date | 26 Feb 2024 - 01 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Exopharm ( ASX:EX1 ) Full Year 2023 Results Key Financial Results Revenue: AU$3.41m (down 19% from FY 2022). Net loss...